Welcome to the HCMA
The HCMA is the preeminent organization improving the lives of those with hypertrophic cardiomyopathy, HCM, preventing untimely deaths and advancing global understanding. Founded in 1996 we are committed to providing support, education, advocacy and advancing research, understanding and care to those with HCM. This website will provide information, support options and member services.
CLINICAL TRIAL NOW RECRUITING
The HCMA is conducting this voluntary survey about investigational drug studies sponsored by MyoKardia Inc., a pharmaceutical company, in collaboration with several clinical sites for the purpose of a clinical trial on a new compound, mavacamten, for use in those with hypertrophic obstructive cardiomyopathy (HOCM) and hypertrophic cardiomyopathy (HCM). Please take a few moments to learn more by clicking here.